Parasitosis importadas en la población inmigrante en España

Balagué, Alba Vilajeliu; Prat, Paula de las Heras; Ortiz-Barreda, Gaby; Delgado, María Jesús Pinazo; Gascón, Joaquim; Bardají, Azucena

doi:10.4321/s1135-57272014000600010

Cited by 16 publications

(15 citation statements)

References 74 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Acute: it lasts 4e8 weeks and is usually asymptomatic or characterized by non-specific symptoms [3,4,7]. Chronic: it begins 2e3 months after the initial infection.…”

Section: Phases and Clinical Evolution/pathogenesismentioning

confidence: 99%

“…About 60e70% of patients will never have clinical manifestations, known as the indeterminate form of Chagas disease. The other 30e40% will progress to a determinate form of Chagas disease that is further classified into four major types: cardiac (20e30%), digestive (10e15%), cardiodigestive (10e15%), and central nervous system (5%) [3,4,7,9,10].…”

Section: Phases and Clinical Evolution/pathogenesismentioning

confidence: 99%

“…There is no general regulation by the European Commission, and therefore, there is no guarantee of controlling Chagas disease transmission in European countries. In Spain, some regions have developed regional screening strategies to control Chagas transmission, the most important "imported" disease to emerge in Spain in recent decades [5,7,8]. However, the high prevalence of this imported disease in a non-endemic area implies the need for specialized pharmaceutical interventions for these patients.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Pharmacist intervention in patients receiving treatment for Chagas disease: An emerging challenge for non-endemic countries

Priegue

Almuedo

Rodriguez

et al. 2017

Infection, Disease & Health

View full text Add to dashboard Cite

Background: Spain has the second highest number of Chagas disease-infected patients among non-endemic countries. However, there is limited knowledge about pharmacist involvement in managing patients with Chagas disease. Method: A retrospective observational study was performed in two periods (before and after intervention) to describe the characteristics of patients with Chagas disease. Pharmacist intervention, based on two pharmacist-visit programs and development of information for patients, was applied to patients under pharmacological treatment in a non-endemic country. Depending on the initial results in 2010e2011, specific pharmacist attention program for patients with Chagas disease was implemented in 2012. The results of 2010e2011 (before intervention) and 2013 (after intervention) were compared. Results: A high number of adverse drug reactions were reported in both periods, 50.0% (2010e2011) vs. 90.9% (2013). With regard to treatment completion, in 2010e2011, 60% achieved the treatment completion criteria (>95% days of treatment) vs. 68.2% in 2013 (p Z 0.580). There was, however, a significant increase in the detection of ADRs in the second period (50.0% vs. 90.9%; p Z 0.003) and an increase in the severity (75% [6/8] of uncompleted treatments were due to ADRs vs. 100% [7/7] in the first and second period, respectively).

show abstract

“…Acute: it lasts 4e8 weeks and is usually asymptomatic or characterized by non-specific symptoms [3,4,7]. Chronic: it begins 2e3 months after the initial infection.…”

Section: Phases and Clinical Evolution/pathogenesismentioning

confidence: 99%

Section: Phases and Clinical Evolution/pathogenesismentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacist intervention in patients receiving treatment for Chagas disease: An emerging challenge for non-endemic countries

Priegue

Almuedo

Rodriguez

et al. 2017

Infection, Disease & Health

View full text Add to dashboard Cite

show abstract

“…VFR = visiting friends and relatives). Das Krankheitsspektrum ist in diesen Fällen anders als bei Touristen: Häufiger importiert werden Tuberkulose, Malaria, Hepatitis und HIV-Infektion [34,42,44] sowie Darmparasiten (62).…”

unclassified

Importierte Erkrankungen

Burchard

2015

Dtsch med Wochenschr

View full text Add to dashboard Cite

With continuing worldwide growth in travel, timely information about the epidemiology of post-travel illness is important. Various travel-related surveillance systems have been established that provide these data. Knowledge about prevalences of important diseases in travelers and migrants can help in the differential diagnosis. On the other hand it has be kept in mind that also rare, but life-threatening diseases can be imported like leptospirosis, viral hemorrhagic fever or amebic liver abcess.

show abstract

“…10 It summarizes 48 studies. The most frequent diagnoses are parasitic intestinal diseases, malaria, Chagas' disease, and filariasis.…”

mentioning

confidence: 99%

La salud de los inmigrantes en España

Delgado-Rodrı́guez

2014

Rev. Esp. Salud Publica

View full text Add to dashboard Cite

Parasitosis importadas en la población inmigrante en España

Abstract: Imported parasitosis is a frequent diagnosis among migrant population. This review highlight the impact that migration has had on the emergence of certain imported parasitic diseases, being Chagas disease the most paradigmatic example.

Cited by 16 publications

References 74 publications

Pharmacist intervention in patients receiving treatment for Chagas disease: An emerging challenge for non-endemic countries

Pharmacist intervention in patients receiving treatment for Chagas disease: An emerging challenge for non-endemic countries

Importierte Erkrankungen

La salud de los inmigrantes en España

Contact Info

Product

Resources

About